Arrhythmia Research Technology Inc.
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Arrhythmia Research Technology Inc. buys out RMDDx Corp.
Arrhythmia Research Technology Inc. (NYSE:HRT) bought out the remaining shares of Prince Edward Island, Canada-based RMDDx Corp. in a stock and options swap.
The Fitchburg, Mass.-based cardiac support technology maker carried out the deal through RMDDx’s U.S.-based subsidiary RMDDxUSA Corp., according to a press release.